Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Current Medical Research and Opinion
|
October 11, 2013
Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review
Ronald Goldenberg
BMJ Case Reports
|
July 22, 2021
Submassive pulmonary embolism with a right heart thrombus
Winnie Yan, Ingrid Gunther, Ali Hafiz, et al.
Annals of Medicine
|
June 24, 2021
Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care
Roopa Mehta, Ronald Goldenberg, Daniel Katselnik, et al.
Canadian Journal of Diabetes
|
May 22, 2017
The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study
Ronnie Aronson, Ronald Goldenberg, Damir Boras, et al.
Journal of Diabetes
|
January 8, 2015
Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database
Ronnie Aronson, Naomi Orzech, Chenglin Ye, et al.
Respiratory Medicine Case Reports
|
December 18, 2020
Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO
Andrew L Lehr, Deane E Smith, Bridget Toy, et al.
Diabetes Care
|
August 13, 2016
Specialist-Led Diabetes Registries and Prevalence of Poor Glycemic Control in Type 2 Diabetes: The Diabetes Registry Outcomes Project for A1C Reduction (DROP A1C)
Ronnie Aronson, Naomi Orzech, Chenglin Ye, et al.
Diabetes Research and Clinical Practice
|
June 17, 2021
Persistence of GLP-1 RA in combination with basal insulin among adults with type 2 diabetes in Canada
Alexander Abitbol, Rick Siemens, Natalie Nightingale, et al.
Diabetes, Obesity & Metabolism
|
March 18, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist and sodium-glucose co-transporter-2 inhibitor use: A post hoc analysis of ONWARDS 1-5
Tina Vilsbøll, Ariel Fu, Monika Kellerer, et al.
Journal of Medical Economics
|
August 25, 2025
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada
David A Garcia, Godfrey Mau, Sumeet Singh, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Current Medical Research and Opinion
|
October 11, 2013
Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review
Ronald Goldenberg
BMJ Case Reports
|
July 22, 2021
Submassive pulmonary embolism with a right heart thrombus
Winnie Yan, Ingrid Gunther, Ali Hafiz, et al.
Annals of Medicine
|
June 24, 2021
Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care
Roopa Mehta, Ronald Goldenberg, Daniel Katselnik, et al.
Canadian Journal of Diabetes
|
May 22, 2017
The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study
Ronnie Aronson, Ronald Goldenberg, Damir Boras, et al.
Journal of Diabetes
|
January 8, 2015
Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database
Ronnie Aronson, Naomi Orzech, Chenglin Ye, et al.
Respiratory Medicine Case Reports
|
December 18, 2020
Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO
Andrew L Lehr, Deane E Smith, Bridget Toy, et al.
Diabetes Care
|
August 13, 2016
Specialist-Led Diabetes Registries and Prevalence of Poor Glycemic Control in Type 2 Diabetes: The Diabetes Registry Outcomes Project for A1C Reduction (DROP A1C)
Ronnie Aronson, Naomi Orzech, Chenglin Ye, et al.
Diabetes Research and Clinical Practice
|
June 17, 2021
Persistence of GLP-1 RA in combination with basal insulin among adults with type 2 diabetes in Canada
Alexander Abitbol, Rick Siemens, Natalie Nightingale, et al.
Diabetes, Obesity & Metabolism
|
March 18, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist and sodium-glucose co-transporter-2 inhibitor use: A post hoc analysis of ONWARDS 1-5
Tina Vilsbøll, Ariel Fu, Monika Kellerer, et al.
Journal of Medical Economics
|
August 25, 2025
Cost-effectiveness of insulin icodec for the treatment of type 2 diabetes in Canada
David A Garcia, Godfrey Mau, Sumeet Singh, et al.
Page
of 5